Payden & Rygel’s Ovintiv OVV Stock Holding History

Payden & Rygel’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,000	Closed	-$128K	–	129
2025 Q1	$128K	Hold	3,000	–	–	0.01%	116
2024 Q4	$122K	Hold	3,000	–	–	0.01%	115
2024 Q3	$115K	Hold	3,000	–	–	0.01%	117
2024 Q2	$141K	Hold	3,000	–	–	0.01%	112
2024 Q1	$156K	Hold	3,000	–	–	0.01%	125
2023 Q4	$132K	Hold	3,000	–	–	0.01%	128
2023 Q3	$143K	Hold	3,000	–	–	0.01%	125
2023 Q2	$114K	Hold	3,000	–	–	0.01%	126
2023 Q1	$108K	Hold	3,000	–	–	0.01%	115
2022 Q4	$152K	Hold	3,000	–	–	0.01%	127
2022 Q3	$138K	Hold	3,000	–	–	0.01%	129
2022 Q2	$133K	Buy	+3,000	New	+$155K	0.01%	133
2022 Q1	–	Sell	-2,670	Closed	-$90K	–	137
2021 Q4	$90K	Sell	2,670 -9,890	-79%	-$353K	﹤0.01%	125
2021 Q3	$413K	Buy	12,560 +6,440	+105%	+$178K	0.02%	102
2021 Q2	$193K	Sell	6,120 -25,000	-80%	-$672K	0.01%	117
2021 Q1	$741K	Buy	+31,120	New	+$666K	0.03%	93

Other funds holding OVV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Payden & Rygel's OVV Position: Q2 2025 in Review

Payden & Rygel sold out of Ovintiv (OVV) in Q2 2025, closing a stake of 3,000 shares — an estimated $128K sold.

Payden & Rygel first reported a position in OVV in Q1 2021 and held it in 16 quarters. The position peaked at $741K in Q1 2021. 534 funds tracked by Wall St. Rank hold OVV as of Q2 2025.

Payden & Rygel reported no remaining Ovintiv position as of Q2 2025 after selling out during the quarter.
Payden & Rygel sold 3,000 Ovintiv shares in Q2 2025, an estimated $128K.
Payden & Rygel first reported a position in Ovintiv in Q1 2021 and held it in 16 quarters.
Payden & Rygel's Ovintiv position peaked at $741K in Q1 2021.
534 funds tracked by Wall St. Rank held Ovintiv as of Q2 2025.

Based on Payden & Rygel's 13F filing for Q2 2025, filed 7 Aug 2025.